Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sees Large Increase in Short Interest

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 63,900 shares, a growth of 428.1% from the December 15th total of 12,100 shares. Based on an average daily volume of 124,300 shares, the days-to-cover ratio is currently 0.5 days.

Fresenius SE & Co. KGaA Trading Down 1.3 %

OTCMKTS:FSNUY traded down $0.12 on Monday, reaching $8.89. The stock had a trading volume of 85,939 shares, compared to its average volume of 127,662. Fresenius SE & Co. KGaA has a 12-month low of $6.57 and a 12-month high of $9.78. The company has a market cap of $19.86 billion, a price-to-earnings ratio of 12.36 and a beta of 1.02. The firm’s fifty day moving average is $8.87 and its two-hundred day moving average is $8.88. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05.

Analyst Ratings Changes

Separately, Citigroup upgraded Fresenius SE & Co. KGaA to a “strong-buy” rating in a research report on Friday, October 25th.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.